Physician

Matthew W Camp, MD

According to 2025 Medicare claims, Matthew Camp, MD (NPI: 1437113917) practices ophthalmology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Pickens, GA. This provider's primary affiliated billing organization is MATTHEW W CAMP OPHTHALMOLOGY LLC (NPI: 1669651055; TIN: 200763767) and primary practice location at 30143-6250.

Camp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,214 traditional Medicare patients, billed 15,124 HCPCS/CPT codes, and received $1,226,412 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 2,126 prescription claims across 479 beneficiaries totaling $249,610 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 14 records totaling $376. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $726,407 to $1,226,412. Similarly, Part D prescription costs have risen steadily, from $131,691 to $249,610. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$613K$1.2M2015 Medicare payment: $726,407 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $840,055 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $920,544 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,016,519 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,176,444 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,178,359 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,162,308 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,161,115 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,174,190 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,226,412 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0836,062$726,407
20161,2816,755$840,055
20171,3187,125$920,544
20181,3088,311$1,016,519
20191,4599,614$1,176,444
20201,3648,368$1,178,359
20211,3898,457$1,162,308
20221,2628,190$1,161,115
20231,35310,812$1,174,190
20241,21415,124$1,226,412

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$174K$348K2015 Drug cost: $131,691 (USD; Tot_Drug_Cst)2016 Drug cost: $184,493 (USD; Tot_Drug_Cst)2017 Drug cost: $204,020 (USD; Tot_Drug_Cst)2018 Drug cost: $241,778 (USD; Tot_Drug_Cst)2019 Drug cost: $281,961 (USD; Tot_Drug_Cst)2020 Drug cost: $281,225 (USD; Tot_Drug_Cst)2021 Drug cost: $348,301 (USD; Tot_Drug_Cst)2022 Drug cost: $333,205 (USD; Tot_Drug_Cst)2023 Drug cost: $326,979 (USD; Tot_Drug_Cst)2024 Drug cost: $249,610 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152781,266$131,691
20162991,437$184,493
20173301,569$204,020
20183551,632$241,778
20193851,665$281,961
20203801,691$281,225
20214161,932$348,301
20224211,951$333,205
20234592,045$326,979
20244792,126$249,610

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system158158$92
67028Injection of drug into eye2051,023$77
92014Established patient complete exam of visual system9941,197$75
92012Established patient problem focused exam of visual system288493$53
92134Imaging of retina8872,164$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost16011,583$102,146
RestasisCyclosporine261,770$37,358
Alphagan PBrimonidine Tartrate221,432$12,043
RhopressaNetarsudil Mesylate21715$9,240
TravoprostTravoprost442,471$8,278

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$376Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew W. Camp, MD?

Tedicare shows public-source Medicare data for Matthew W. Camp, MD (NPI 1437113917), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew W. Camp, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew W. Camp, MD?

Matthew W. Camp, MD is linked to MATTHEW W CAMP OPHTHALMOLOGY LLC (billing NPI 1669651055) in the available physician profile data.

Does Matthew W. Camp, MD have Open Payments data?

Matthew W. Camp, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.